---
**Version**: 1.0.0  
**Date**: 2025-12-05  
**Model**: Claude Opus 4.5 (Thinking)  
**References**:  
- [refs/5_more/pmfkit_optimize_guide.md](../refs/5_more/pmfkit_optimize_guide.md) — Three-stage optimization pipeline (EVALUATE→SUGGEST→IMPROVE)  
- [refs/5_more/pmfkit_optimize_quick_ref.md](../refs/5_more/pmfkit_optimize_quick_ref.md) — Quick reference for evaluation methodology  
- [refs/5_more/pmfkit_optimize_code_examples.md](../refs/5_more/pmfkit_optimize_code_examples.md) — Implementation patterns  
---

# Evaluation: Example Plan Documents

## Overview

Two PMF research plans for **agentii-kit** at different abstraction levels:

| Version | Focus | Duration | Scope |
|---------|-------|----------|-------|
| **my-product_0_0_2** | Website/gallery PMF discovery | 16 weeks (4 phases) | End-user marketplace |
| **my-product_0_0_3** | Platform/marketplace infrastructure | 12+ weeks (3 phases) | Kit creator ecosystem |

Both demonstrate excellent application of the PMF-Kit research methodology.

---

# Evaluation: `my-product_0_0_2/specs/001-agentii-kit-pmf/plan.md`

## Rating: 9.5/10 — Exceptional PMF research plan

### ✅ Strengths

**1. Comprehensive Research Questions (lines 12-48)**
- 6 well-defined questions with explicit hypotheses
- Each question has measurable success thresholds (e.g., "70%+ of interviewed personas")
- Clear evidence sources specified (N=20 interviews, N=18 usability tests)

**2. Two-Sided Marketplace Rigor**
- Questions balanced across creators (Q1, Q4) and users (Q1, Q3)
- Network effects explicitly measured (Q5: R² > 0.6 correlation)
- Cross-side conversion tracked (10%+ users → creators)

**3. PDCA Cycle Implementation (lines 151-167, 229-244, 299-319)**
- Weekly Do/Check/Act rhythm for each phase
- Explicit checkpoints with adjustment triggers
- Mid-phase course correction built in

**4. Constitution Alignment (lines 63-80)**
- All 7 constitution principles explicitly checked ✅
- Methodology validation against PMF-Kit core principles
- Traceable to spec.md hypotheses

**5. Risk Mitigation (lines 425-459)**
- 4 specific risks with concrete mitigation strategies
- Fallback plans for each risk scenario
- Pivot options documented (e.g., GitHub barrier → web UI alternative)

**6. Budget & Resource Planning (lines 498-502)**
- Realistic budget: $2,400 total for Phases 1-3
- Incentive structure: $50/participant
- Tool stack specified (Zoom, Calendly, Notion, Typeform, Vercel)

**7. Success Criteria Table (lines 404-422)**
- Clear Go thresholds for each phase/question
- Quantified metrics (75%+ completion, >= 4.0 satisfaction)
- Phase-specific criteria enabling independent validation

### ⚠️ Issues

**Issue 1: Directory Path Inconsistency**

```
Line 65: alignment with agentii-kit constitution principles (.specify/memory/constitution.md)
Line 467: (.specify/memory/constitution.md) - DONE
Line 472: Run `.specify/scripts/bash/update-agent-context.sh`
```

Uses `.specify/` but should be `.pmf/` or `.agentii/` to match the kit's namespace (same issue as constitution.md).

**Issue 2: Missing /pmfkit.optimize Integration**

No reference to the EVALUATE→SUGGEST→IMPROVE optimization pipeline from `refs/5_more/`. Could strengthen:
- Phase 3 channel testing with prompt optimization
- Hypothesis refinement between phases

**Issue 3: Phase 3 Network Effects Measurement May Be Premature**

Requires R² > 0.6 correlation between kit count and user signups (line 324), but with only 10-15 seed kits, sample size may be insufficient for robust statistical correlation.

**Recommendation**: Lower threshold to R² > 0.4 for Phase 3, require R² > 0.6 only at scale (Phase 4+).

---

# Evaluation: `my-product_0_0_3/specs/001-kit-marketplace/plan.md`

## Rating: 8/10 — Solid platform research plan with structural gaps

### ✅ Strengths

**1. Multi-Agent Validation (lines 95-98)**
- H4.1 explicitly tests Claude Code + Cursor + Copilot compatibility
- Technical validation sessions integrated into Phase 1
- Agent-agnostic design principle validated empirically

**2. Hypothesis Cluster Organization**
- 5 hypothesis clusters (H1-H5) map cleanly to research questions
- Creator JTBD (H1.1-1.3) + User JTBD (H2.1-2.3) clearly separated
- Market signals (H3, H5) and technical feasibility (H4) distinct tracks

**3. Research Traceability Table (lines 225-235)**
- Direct mapping from spec.md → hypotheses → research questions → instruments → timeline
- Excellent for audit trail and stakeholder communication

**4. Tiered Phase Exit Criteria (lines 124-128)**
- Three outcomes defined: GO, PIVOT, NO-GO
- PIVOT specifically addresses 1-2 clusters needing refinement
- Strategic hold option for fundamental redesign

**5. Compressed Timeline**
- 4-week Phase 1 (vs. 6 weeks in 0_0_2)
- More aggressive for platform infrastructure focus
- Weekly PDCA table (lines 117-122) enables rapid iteration

### ⚠️ Issues

**Issue 1: Less Detailed Than 0_0_2**

| Dimension | my-product_0_0_2 | my-product_0_0_3 |
|-----------|------------------|------------------|
| Research Questions | 6 detailed with thresholds | 4 high-level |
| Risk Mitigation | 4 specific risks | Not documented |
| Budget | $2,400 specified | Not specified |
| Phase 3 Detail | 6 weeks with channel breakdown | 4-6 weeks, less granular |

**Issue 2: Constitution Reference Path Correct but Different**

```
Line 54: Verify alignment with agentii-kit principles (/.pmf/memory/constitution.md)
```

Uses `/.pmf/` which is correct for PMF-Kit parent, but 0_0_3's constitution uses `.agentii/` directory. Inconsistency between plan and constitution.

**Issue 3: Missing Network Effects Measurement**

Unlike 0_0_2 (Q5: R² > 0.6 correlation), 0_0_3 doesn't explicitly measure marketplace network effects. For a platform constitution, this is a gap.

**Issue 4: Phases 2-3 Underspecified**

Phase 2 (lines 140-168) and Phase 3 (lines 170-196) are marked as "post-Phase 1 contingent" but lack:
- Specific research activities
- PDCA rhythm for each phase
- Risk mitigation strategies

**Issue 5: Missing Budget and Incentive Structure**

No participant incentive or budget estimate. For 24+ interviews + 13-18 usability tests, this is a planning gap.

---

# Comparative Analysis

| Dimension | my-product_0_0_2 | my-product_0_0_3 |
|-----------|------------------|------------------|
| **Research Questions** | 6 (detailed) | 4 (high-level) |
| **Phases** | 4 (0-3), 16 weeks | 3 (1-3), 12+ weeks |
| **PDCA Detail** | Weekly rhythm per phase | Weekly table, less detail in Phase 2-3 |
| **Constitution Alignment** | 7 principles checked | 5 principles checked |
| **Risk Mitigation** | 4 risks documented | Not documented |
| **Budget** | $2,400 estimated | Not specified |
| **Network Effects** | Q5 with R² threshold | Not measured |
| **Multi-Agent Testing** | Not explicit | H4.1 explicit |
| **Namespace** | `.specify/` (incorrect) | `/.pmf/` (correct but inconsistent with constitution) |

---

# Recommendations

## For 0_0_2 (Website Plan)

| Priority | Action |
|----------|--------|
| **P1** | Fix directory paths: `.specify/` → `.pmf/` or `.agentii/` |
| **P2** | Add `/pmfkit.optimize` integration for Phase 3 channel optimization |
| **P2** | Lower Phase 3 network effects threshold (R² > 0.4) until scale achieved |
| **P3** | Add multi-agent compatibility testing (currently missing) |

## For 0_0_3 (Platform Plan)

| Priority | Action |
|----------|--------|
| **P1** | Add budget and incentive structure |
| **P1** | Expand Phase 2-3 with PDCA rhythm and specific activities |
| **P1** | Add risk mitigation section |
| **P2** | Add network effects measurement (Q5 equivalent) |
| **P2** | Align namespace with constitution (`.agentii/` vs `/.pmf/`) |
| **P3** | Match detail level of 0_0_2 research questions |

## Cross-Plan

These plans describe the **same project** (agentii-kit) but:
- 0_0_2 is more complete and production-ready
- 0_0_3 has unique multi-agent validation but needs more detail

Consider:
1. **Merge best practices**: Use 0_0_2 structure with 0_0_3's multi-agent testing
2. **Explicit relationship**: 0_0_3 could be a "Platform Validation" sub-plan of 0_0_2

---

# Alignment with `/pmfkit.optimize` Methodology

Both plans would benefit from integrating the optimization pipeline from `refs/5_more/`:

| Stage | Application |
|-------|-------------|
| **EVALUATE** | Use multi-judge evaluation for interview synthesis quality |
| **SUGGEST** | Apply diagnostic analysis to identify research gaps |
| **IMPROVE** | Optimize channel messaging using MIPROv2/TextGrad |
| **VALIDATE** | A/B test landing page copy before Phase 3 launch |
| **ITERATE** | Monitor Phase 3 metrics for degradation, trigger re-optimization |

Neither plan currently references this pipeline, which is a missed opportunity for hypothesis refinement and channel optimization.

---

# Verdict

| Plan | Rating | Summary |
|------|--------|---------|
| **0_0_2** | 9.5/10 | Exceptional PMF research plan with comprehensive detail, PDCA cycles, risk mitigation, and budget. Minor namespace issues. |
| **0_0_3** | 8/10 | Solid platform plan with strong multi-agent validation but underspecified Phases 2-3, missing budget and risk mitigation. |

**Winner for production use**: 0_0_2 — more complete, actionable, and ready for execution.

**0_0_3's unique contribution**: Multi-agent compatibility testing (H4.1) should be merged into 0_0_2.
